Pfizer is a pharmaceutical company that discovers, develops, and sells medications across multiple therapeutic areas globally. The company operates three business segments and manufactures products for internal medicine conditions, vaccines, inflammation and immunology disorders, rare diseases, infections, oncology, and biosimilar drugs. Its portfolio includes treatments for cardiovascular disease, migraines, various cancers, hemophilia, and COVID-19, along with partnerships with other pharmaceutical firms and research collaborations focused on artificial intelligence applications in drug development.

entry readiness 12 · NOT READY · exit proximity 0

Value area 24.29–27.53 · 14% of 120d volume overhead · clean runway